Stay updated with breaking news from David Heuz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regulatory News: Medincell (Paris:MEDCL): Christophe Douat, CEO, and Richard Malamut, CMO, will present Medincell's portfolio and R&D pipeline at the Jefferies Global Healthcare Conference on
MONTPELLIER, France, April 08, 2024--Regulatory News: Global health agency Unitaid has awarded Medincell (Paris:MEDCL) an extension grant of up to US$ 6 million over three years to fund the clinical phase 1 activities of long-acting injectable mdc-STM. If proven safe, effective, and acceptable, mdc-STM could have a significant impact on transmission of malaria among vulnerable populations in high-transmission areas.
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News:MedinCell (Paris:MEDCL):“I am stepping down from the Supervisory Board as I have reached the mandated age limit. More importantly, I do so with utmost confidence in our current management team's ability to move the company forward, strengthen our partnerships, an...
MedinCell’s partner Teva to receive R&D funding from Royalty Pharma of up to $125 million to further accelerate the development of olanzapine LAI, a long-acting subcutaneous injectable olanzapine for schizophrenia using MedinCell’s technology. (Access here Teva and Royalty Pharma today’s joint press release for more...
MONTPELLIER, France--(BUSINESS WIRE)--Nov 13, 2023--